Corinne H. Nevinny, Director at ONYX PHARMACEUTICALS INC (ONXX), sold 1,500 shares at $131.26 ($197K) on 2013-07-30, disclosed to the SEC on 2013-07-31.
Scheduled sale ($197k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| NBIX | SELL | 2018-05-09 | $416K | — | Filing → |
| NBIX | SELL | 2017-05-08 | $270K | — | Filing → |
| NBIX | SELL | 2016-08-09 | $243K | — | Filing → |